Verrica Pharmaceuticals Inc.
Develops topical therapies for skin diseases like molluscum contagiosum and common warts.
VRCA | US
Overview
Corporate Details
- ISIN(s):
- US92511W1080
- LEI:
- Country:
- United States of America
- Address:
- 10 NORTH HIGH STREET, 19380 WEST CHESTER
- Website:
- https://verrica.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company that develops and commercializes medications for skin diseases requiring medical intervention. The company is focused on providing innovative and accessible treatments for underserved patients. Its lead commercial product, YCANTH®, is a topical therapy for the treatment of molluscum contagiosum. Verrica is also advancing YCANTH® through clinical trials for the treatment of common warts and is developing other pipeline candidates for conditions such as basal cell carcinoma. The company aims to improve the efficiency of dermatological care for patients, physicians, and payers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Verrica Pharmaceuticals Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Verrica Pharmaceuticals Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Verrica Pharmaceuticals Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
